NORTHWEST BIOTHERAPEUTICS INCNWBO
Market cap
$364.6M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 20 | 23 | 24 | - | - | 0 | 1 | - | - | - | - | - | - | - |
| Cash from operations | -15 | -23 | -38 | -55 | -79 | -56 | -36 | -35 | -32 | -32 | -38 | -53 | -54 | -57 |
| Capital expenditures | -5 | -5 | -5 | - | -7 | -5 | -0 | - | -0 | -7 | -6 | -3 | -3 | -1 |
| Cash from investing | -0 | -0 | 0 | -36 | -7 | -5 | 0 | 45 | -0 | -8 | -6 | -3 | -3 | -1 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | 119 | 150 | 199 | 86 | 94 | 38 | 34 | 8 | 10 | 53 | 48 | 42 | 53 | 57 |
| Free cash flow | - | |||||||||||||
| FCF margin (%) | - | - | - | - | - | - |